Equity Overview
Price & Market Data
Price: $0.158
Daily Change: -$0.0654 / 41.39%
Range: $0.15 - $0.23
Market Cap: $1,737,716
Volume: 5,898,746
Performance Metrics
1 Week: -10.23%
1 Month: -24.51%
3 Months: -63.29%
6 Months: -79.81%
1 Year: -95.82%
YTD: -81.71%
Company Details
Employees: 9
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.